Position in AZN
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$33,470,205
-$1,420,774 QoQ
Shares Held
176,512
-0.2% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
1.11%
of 13F equity value
Holder Rank
#186
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BECKER CAPITAL MANAGEMENT INC holds $223,808,539 across 11 Drug Manufacturers - General names. AZN ranks #3 (15.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
246,132 | $62,510,144 | |
| 2 | MRK |
Merck & Co., Inc.
|
268,226 | $34,467,041 | |
| 3 | AZN |
Astrazeneca PLC
This page
|
176,512 | $33,470,205 | |
| 4 | AMGN |
Amgen Inc
|
85,085 | $30,810,980 | |
| 5 | LLY |
ELI LILLY & Co
|
24,740 | $29,673,900 | |
| 6 | SNY |
Sanofi
|
346,469 | $14,780,367 | |
| 7 | PFE |
Pfizer Inc
|
469,672 | $11,309,701 | |
| 8 | ABBV |
AbbVie Inc.
|
15,542 | $3,910,988 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $33,470,205 | 176,512 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $34,890,979 | 176,914 | Shares | Sole | 2026-05-11 | |
| No filing history on record for this holder in this stock. | ||||||